Chromogenic In Situ Hybridization
John M.S. Bartlett(Edinburgh Cancer Research), Keith Miller(University College London), Yvonne Connolly(Tallaght University Hospital), Ian O. Ellis(University of Nottingham), Fiona Campbell(University of Birmingham), Silvana Di Palma(Royal Surrey County Hospital), Merdol Ibrahim(University College London), Elaine W. Kay(Trinity College Dublin), Peter Wencyk(Nottingham City Hospital), Anthony O’Grady(Beaumont Hospital), Bharat Jasani(Cardiff University), John Morgan(Purdue University West Lafayette), Jane Starczynski(Ontario Institute for Cancer Research)
Cited by 45
Related Papers
What is meant by intention to treat analysis? Survey of published randomised controlled trials
|BMJ|1999|2.2k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k
Effectiveness of brief alcohol interventions in primary care populations
|Cochrane Database of Systematic Reviews|2018|1.7k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k